Even though the market didn’t give a toss, I think it is a huge milestone that NEU is now in a phase3 trial, and what's more, it is in a definitive, one-only-needed, phase 3 trial.
how many other Australian biotechs are currently in a phase 3 trial?
MSB is.
Telix is, in theory, for its renal cancer imagining product, but that trial appears to be barely alive, as far I can work out from lack of recruitment progress in TLX's announcements.
any other companies currently doing phase 3 trials?
(PAR is currently applying to do one. BOT says they plan to apply to do one.)
anyway, commencing a phase 3 trial is a huge milestone, and puts NEU into a rarefied class!
Ann: Phase 3 trial of trofinetide in Rett syndrome commences, page-13
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $14.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.23 | 3278 | 1 |
View Market Depth
| Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |